A multiplex RT-PCR for the detection of parainfluenza viruses 1-3 in clinical samplesCORNE, J. M; GREEN, S; SANDERSON, G et al.Journal of virological methods. 1999, Vol 82, Num 1, pp 9-18, issn 0166-0934Article

In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2PRECIOUS, B; YOUNG, D. F; ANDREJEVA, L et al.Journal of general virology. 2005, Vol 86, pp 151-158, issn 0022-1317, 8 p., 1Article

Fixation of Oligosaccharides to a Surface May Increase the Susceptibility to Human Parainfluenza Virus 1, 2, or 3 Hemagglutinin-NeuraminidaseTAPPERT, Mary M; SMITH, David F; AIR, Gillian M et al.Journal of virology. 2011, Vol 85, Num 23, pp 12146-12159, issn 0022-538X, 14 p.Article

Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C proteinMALUR, Achut G; CHATTOPADHYAY, Santanu; MAITRA, Ratan K et al.Journal of virology. 2005, Vol 79, Num 12, pp 7877-7882, issn 0022-538X, 6 p.Article

Quantitative RT Real Time PCR and indirect immunofluorescence for the detection of human parainfluenza virus 1, 2, 3ELENA TERLIZZI, Maria; BERGALLO, Massimiliano; SIDOTI, Francesca et al.Journal of virological methods. 2009, Vol 160, Num 1-2, pp 172-177, issn 0166-0934, 6 p.Article

Clinical courses of croup caused by influenza and parainfluenza virusesPELTOLA, Ville; HEIKKINEN, Terho; RUUSKANEN, Olli et al.The Pediatric infectious disease journal. 2002, Vol 21, Num 1, pp 76-78, issn 0891-3668Article

African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infectionDURBIN, A. P; ELKINS, W. R; MURPHY, B. R et al.Vaccine. 2000, Vol 18, Num 22, pp 2462-2469, issn 0264-410XArticle

The epidemiology of parainfluenza virus infection in lung transplant recipientsVILCHEZ, Regis A; MCCURRY, Kenneth; DAUBER, James et al.Clinical infectious diseases. 2001, Vol 33, Num 12, pp 2004-2008, issn 1058-4838Article

Simultaneous detection and identification of human parainfluenza viruses 1, 2, and 3 from clinical samples by multiplex PCRECHEVARRIA, J. E; ERDMAN, D. D; SWIERKOSZ, E. M et al.Journal of clinical microbiology (Print). 1998, Vol 36, Num 5, pp 1388-1391, issn 0095-1137Article

Comparison of three monoclonal antibody pools for the detection of respiratory viral antigen in respiratory secretionsTAYLOR, P; DAVE, J. R; GAYA, H et al.European journal of clinical microbiology & infectious diseases (Print). 1998, Vol 17, Num 7, pp 522-524, issn 0934-9723Article

Detection and identification of human parainfluenza viruses 1, 2, 3, and 4 in clinical samples of pediatric patients by multiplex reverse transcription-PCRAGUILAR, J. C; PEREZ-BRENA, M. P; GARCIA, M. L et al.Journal of clinical microbiology (Print). 2000, Vol 38, Num 3, pp 1191-1195, issn 0095-1137Article

Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterpartsSKIADOPOULOS, M. H; TAO TAO; SURMAN, S. R et al.Vaccine. 1999, Vol 18, Num 5-6, pp 503-510, issn 0264-410XArticle

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challengeTAO, T; SKIADOPOULOS, M. H; DURBIN, A. P et al.Vaccine. 1999, Vol 17, Num 9-10, pp 1100-1108, issn 0264-410XArticle

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3TAO TAO; DAVOODI, F; CHO, C. J et al.Vaccine. 2000, Vol 18, Num 14, pp 1359-1366, issn 0264-410XArticle

Completion of the full-length genome sequence of human parainfluenza virus types 4A and 4B: sequence analysis of the large protein genes and gene start, intergenic and end sequencesKOMADA, Hiroshi; KAWANO, Mitsuo; TAMAKI, Tatsuya et al.Archives of virology. 2011, Vol 156, Num 1, pp 161-166, issn 0304-8608, 6 p.Article

Human Parainfluenza Virus Type 2 L Protein Regions Required for Interaction with Other Viral Proteins and mRNA CappingNISHIO, Machiko; TSURUDOME, Masato; GARCIN, Dominique et al.Journal of virology. 2011, Vol 85, Num 2, pp 725-732, issn 0022-538X, 8 p.Article

Identification of Human Parainfluenza Virus Type 2 (HPIV-2) V Protein Amino Acid Residues That Reduce Binding of V to MDA5 and Attenuate HPIV-2 Replication in Nonhuman PrimatesSCHAAP-NUTT, Anne; HIGGINS, Caraline; AMARO-CARAMBOT, Emerito et al.Journal of virology. 2011, Vol 85, Num 8, pp 4007-4019, issn 0022-538X, 13 p.Article

Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unitHARVALA, Heli; GAUNT, Eleanor; MCLNTYRE, Chloe et al.The Journal of infection. 2012, Vol 65, Num 3, pp 246-254, issn 0163-4453, 9 p.Article

Construction of a live-attenuated bivalent vaccine virus against human parainfluenza virus (PIV) types 1 and 2 using a recombinant PIV3 backboneTAO TAO; SKIADOPOULOS, Mario H; DAVOODI, Fatemeh et al.Vaccine. 2001, Vol 19, Num 27, pp 3620-3631, issn 0264-410XArticle

The C Proteins of Human Parainfluenza Virus Type 1 Limit Double-Stranded RNA Accumulation That Would Otherwise Trigger Activation of MDA5 and Protein Kinase RBOONYARATANAKORNKIT, Jim; BARTLETT, Emmalene; SCHOMACKER, Henrick et al.Journal of virology. 2011, Vol 85, Num 4, pp 1495-1506, issn 0022-538X, 12 p.Article

Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effectNISHIO, Machiko; TSURUDOME, Masato; ITO, Morihiro et al.Journal of virology. 2005, Vol 79, Num 23, pp 14756-14768, issn 0022-538X, 13 p.Article

N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding SiteMISHIN, Vasiliy P; WATANABE, Makiko; TAYLOR, Garry et al.Journal of virology. 2010, Vol 84, Num 6, pp 3094-3100, issn 0022-538X, 7 p.Article

Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (hexaplex)JIANG FAN; HENRICKSON, K. J; SAVATSKI, L. L et al.Clinical infectious diseases. 1998, Vol 26, Num 6, pp 1397-1402, issn 1058-4838Conference Paper

A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infantsBERNSTEIN, David I; FALLOON, Judith; TINGTING YI et al.Vaccine. 2011, Vol 29, Num 40, pp 7042-7048, issn 0264-410X, 7 p.Article

Human parainfluenza virus 4 outbreak and the role of diagnostic testsLAU, Susanna K. P; TO, Wing-Kin; YUNG, Raymond W. H et al.Journal of clinical microbiology (Print). 2005, Vol 43, Num 9, pp 4515-4521, issn 0095-1137, 7 p.Article